Product image of Mepivacaína Normogen (Mepivacaine Hydrochloride) supplied by GNH India

Mepivacaína Normogen

Active Ingredient:
Mepivacaine Hydrochloride
Origin:
EU

Mepivacaína Normogen (Mepivacaine Hydrochloride)

Mepivacaine Hydrochloride, the active ingredient in Mepivacaína Normogen, is a local anesthetic presented as a sterile solution for infiltration and perineural use. It provides reversible loss of sensation for dental, minor surgical and peripheral nerve block procedures in adult patients.
GNH India supplies Mepivacaína Normogen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Laboratorios Normon, S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Mepivacaína Normogen is a local anesthetic used to achieve temporary loss of sensation in tissues supplied by peripheral nerves.

  • Dental procedures: provides local anesthesia for tooth extractions, restorations and periodontal surgery.
  • Minor surgical procedures: enables infiltration anesthesia for skin incisions, biopsies and suturing.
  • Peripheral nerve blocks: facilitates perineural anesthesia for limb and extremity surgeries.

How It Works

  • Mepivacaine hydrochloride reversibly binds to voltage‑gated sodium channels on neuronal membranes, stabilising the inactive state of the channel. This inhibition prevents the rapid influx of sodium ions required for depolarisation, thereby blocking the initiation and propagation of nerve impulses and producing a localized loss of sensation without affecting consciousness.

Side Effects

Mepivacaína Normogen may cause a range of adverse reactions following administration.

Common Side Effects

  • Transient numbness or tingling at the injection site.
  • Mild dizziness or light‑headedness.
  • Headache.
  • Nausea or metallic taste.
  • Temporary swelling or bruising at the site.

Serious or Rare Side Effects

  • Allergic reactions such as rash, urticaria or anaphylaxis.
  • Cardiovascular toxicity including arrhythmias, hypotension or cardiac arrest.
  • Central nervous system toxicity presenting as seizures or prolonged loss of consciousness.
  • Methemoglobinemia or prolonged numbness beyond the expected duration.

Precautions & Warnings

Before using Mepivacaína Normogen, consider the following safety measures.

  • Allergy assessment: verify no hypersensitivity to amide‑type local anesthetics.
  • Cardiovascular status: avoid or use with caution in patients with significant arrhythmias or conduction disorders.
  • Dosage limits: adhere to the maximum recommended dose based on body weight and site of administration.
  • Pregnancy and lactation: use only if the potential benefit justifies the potential risk to the fetus or infant.
  • Renal or hepatic impairment: consider dose reduction and monitor for prolonged effects.
  • Store at below 25°C: keep in the original container, protect from light and moisture.

Avoid Interactions

Mepivacaína Normogen can interact with other medicines; awareness of the most relevant interactions helps minimise risk.

Major Interactions (Avoid)

  • Class I antiarrhythmic agents (e.g., quinidine, procainamide): may increase cardiotoxicity.
  • Beta‑adrenergic antagonists (e.g., propranolol): can potentiate hypotensive effects.
  • Monoamine oxidase inhibitors: risk of severe hypertension when combined with vasoconstrictors.

Moderate Interactions (Monitor Closely)

  • Concurrent use of other local anesthetics: cumulative systemic toxicity.
  • Central nervous system depressants (e.g., benzodiazepines, opioids): may enhance CNS depression.
  • Diuretics: may alter plasma protein binding and affect drug distribution.

Frequently Asked Questions

Mepivacaína Normogen is a sterile solution of the local anesthetic mepivacaine hydrochloride. It is employed by qualified healthcare professionals to provide temporary loss of sensation for dental treatments, minor surgical procedures, and peripheral nerve block techniques, allowing procedures to be performed without pain.

Mepivacaine blocks voltage‑gated sodium channels on nerve membranes, stabilising them in an inactive state. This prevents the rapid influx of sodium ions needed for depolarisation, thereby inhibiting the generation and propagation of nerve impulses and producing a reversible, localized anesthetic effect.

The dose of Mepivacaína Normogen is determined by the prescribing clinician based on the type of procedure, patient weight, age, and overall health. Only a qualified medical professional should calculate and administer the appropriate amount.

Safety data for mepivacaine in pregnancy and lactation are limited. It should be used only when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision must be made by the treating physician.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Mepivacaine is an amide‑type local anesthetic with a slightly faster onset and intermediate duration compared with lidocaine. It tends to produce less vasodilation, often allowing use without a vasoconstrictor, and may be preferred in patients where a rapid, moderate‑length block is desired.

Store the product at or below 25 °C in its original sealed container, protecting it from light, moisture and extreme temperatures. Do not freeze the solution. Inspect the vial for particulate matter or discoloration before use and discard if any abnormalities are observed.

The solution is administered by a trained clinician via infiltration into the target tissue or perineural injection around a nerve bundle. The route is strictly parenteral; it is not intended for oral, topical or intrathecal use.

Serious adverse events include severe allergic reactions (anaphylaxis), cardiovascular toxicity such as arrhythmias or cardiac arrest, and central nervous system toxicity manifesting as seizures or prolonged loss of consciousness. Immediate medical attention is required if any of these occur.

Patients with a known hypersensitivity to mepivacaine or other amide‑type local anesthetics, those with severe cardiac conduction disorders, uncontrolled epilepsy, or significant hepatic or renal impairment should avoid its use unless a specialist determines that benefits outweigh risks.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Mepivacaine Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT